Loading…
Pharmacological disruption of calcium channel trafficking by the α 2 δ ligand gabapentin
The mechanism of action of the antiepileptic and antinociceptive drugs of the gabapentinoid family has remained poorly understood. Gabapentin (GBP) binds to an exofacial epitope of the α 2 δ-1 and α 2 δ-2 auxiliary subunits of voltage-gated calcium channels, but acute inhibition of calcium currents...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2008-03, Vol.105 (9), p.3628-3633 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The mechanism of action of the antiepileptic and antinociceptive drugs of the gabapentinoid family has remained poorly understood. Gabapentin (GBP) binds to an exofacial epitope of the α
2
δ-1 and α
2
δ-2 auxiliary subunits of voltage-gated calcium channels, but acute inhibition of calcium currents by GBP is either very minor or absent. We formulated the hypothesis that GBP impairs the ability of α
2
δ subunits to enhance voltage-gated Ca
2+
channel plasma membrane density by means of an effect on trafficking. Our results conclusively demonstrate that GBP inhibits calcium currents, mimicking a lack of α
2
δ only when applied chronically, but not acutely, both in heterologous expression systems and in dorsal root-ganglion neurons. GBP acts primarily at an intracellular location, requiring uptake, because the effect of chronically applied GBP is blocked by an inhibitor of the system-L neutral amino acid transporters and enhanced by coexpression of a transporter. However, it is mediated by α
2
δ subunits, being prevented by mutations in either α
2
δ-1 or α
2
δ-2 that abolish GBP binding, and is not observed for α
2
δ-3, which does not bind GBP. Furthermore, the trafficking of α
2
δ-2 and Ca
V
2 channels is disrupted both by GBP and by the mutation in α
2
δ-2, which prevents GBP binding, and we find that GBP reduces cell-surface expression of α
2
δ-2 and Ca
V
2.1 subunits. Our evidence indicates that GBP may act chronically by displacing an endogenous ligand that is normally a positive modulator of α
2
δ subunit function, thereby impairing the trafficking function of the α
2
δ subunits to which it binds. |
---|---|
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0708930105 |